Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles

Journal of Nanoscience and Nanotechnology

Volumn 9, Issue 8, 2009, Pages 5091-5098

  Hekmatara, Telli ^a   Gelperina, Svetlana ^b   Vogel, Vitali ^a   Yang, Shang Ray ^a   Kreuter, Jörg ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Nanosystem LTD   (Russian Federation)

Author keywords

Loperamide; Nanoparticles; Organic solvents; Paclitaxel; Poly(butyl cyanoacrylate); Tail flick test; Water insoluble drugs

Indexed keywords

ANALGESIC EFFECT; BLOOD-BRAIN BARRIER; BUTYL CYANOACRYLATE; CYANOACRYLATES; ENCAPSULATION EFFICIENCY; HYDROPHOBIC DRUG; INSOLUBLE DRUG; LOPERAMIDE; METHOXY; NANOPARTICLE MORPHOLOGY; ORGANIC MEDIA; PACLITAXEL; PHOSPHOETHANOLAMINE; PHYSICOCHEMICAL PARAMETERS; POLOXAMER; POLY(BUTYL CYANOACRYLATE); SODIUM SALT; TAIL-FLICK TEST;

DICHLOROMETHANE; ENCAPSULATION; ETHANOL; GLUCOSE; METHANOL; ORGANIC SOLVENTS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

NANOPARTICLES;

ENBUCRILATE; NANOPARTICLE; WATER;

ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMISTRY; GAS CHROMATOGRAPHY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLUBILITY;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GAS; ENBUCRILATE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; WATER;

EID: 68249139283     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2009.GR05     Document Type: Article

References (23)

1. L. Barraud, P. Merle, E. Soma, L. Lefrancois, S. Guerret, M. Chevallier, C. Dubernet, P. Couvreur, C. Trepo, and L. Vitvitski, Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J. Hepatol. 42, 736 (2005).
2. S. C. Steiniger, J. Kreuter, A. S. Khalansky, I. N. Skidan, A. I. Bobruskin, Z. S. Smirnova, S. E. Severin, R. Uhl, M. Kock, K. D. Geiger, and S. E. Gelperina, Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int. J. Cancer. 109, 759 (2004).
3. C. Vauthier, C. Dubernet, E. Fattal, H. Pinto-Alphandary, and P. Couvreur, Poly (alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 55, 519 (2003).
4. M. Youssef, E. Fattal, M. J. Alonso, L. Roblot-Treupel, J. Sauzieres, C. Tancrede, A. Omnes, P. Couvreur, and A. Andremont, Effectiveness of nanoparticle-bound ampicillin in the treatment of listeria monocytogenes infection in athymic nude mice. Antimicrob. Agents Chemother. 32, 1204 (1988).
5. R. N. Alyautdin, V. E. Petrov, K. Langer, A. Berthold, D. A. Kharkevich, and J. Kreuter, Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm. Res. 14, 325 (1997).
6. P. H. Beck, J. Kreuter, W. E. G. Müller, and W. Schatton, Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles. Eur. J. Pharm. Biopharm. 40, 134 (1994).
7. D. Duchene, G. Ponchel, and D. Wouessidjewe, Cyclodextrins in targeting. Application to nanoparticles. Adv. Drug Deliv. Rev. 36, 29 (1999).
8. V. Vogel, K. Langer, S. Balthasar, P. Schuck, W. Mächtle, W. Haase, J. A. Van den Broek, C. Tziatios, and D. Schubert, Characterizationof serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy. Progr. Colloid Polym. Sci. 119, 31 (2002).
9. K. Langer, S. Balthasar, V. Vogel, N. Dinauer, H. von Briesen, and D. Schubert, Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm. 257, 169 (2003).
10. P. Schuck and P. Rossmanith, Determination of the sedimentation coefficient distribution by least-squares boundary modeling. Biopolymers 54, 328 (2000).
11. H. Chen, F. Gaul, D. Guo, and A. Maycock, Determination of loperamide in rat plasma and bovine serum albumin by LC. J. Pharm. Biomed. Anal. 22, 555 (2000).
12. A. Krishnadas, I. Rubinstein, and H. Onyuksel, Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm. Res. 20, 297 (2003).
13. K. Langer, E. Seegmüller, A. Zimmer, and J. Kreuter, Characterisation of polybutylcyanoacrylate nanoparticles: I. Quantification of PBCA polymer and dextrans. Int. J. Pharm. 110, 21 (1994).
14. R. T. Liggins, W. L. Hunter, and H. M. Burt, Solid-state characterization of paclitaxel. J. Pharm. Sci. 86, 1458 (1997).
15. Merck Index, 13th edn., Loperamide (2001), p. 5592.
16. J. H. Kim, Prepurification of paclitaxel by micelle and precipitation. Process Biochem. 39, 1567 (2004).
17. A. Bootz, V. Vogel, D. Schubert, and J. Kreuter, Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly (butyl cyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 57, 369 (2004).
18. A. Ambruosi, S. Gelperina, A. Khalansky, S. Tanski, A. Theisen, and J. Kreuter, Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly (butyl cyanoacrylate) nanoparticles in a rat glioma model. Microencapsul. 23, 582 (2006).
19. P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Bauduin, and P. Speiser, Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31, 331 (1979).
20. European Pharmacopoeia, 5th edn., Residual Solvents (2005), Chap. 5.4, pp. 507-510.
21. A. Mitra and S. Lin, Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. J. Pharm. Pharmacol. 55, 895 (2003).
22. R. N. Upton, Cerebral uptake of drugs in humans. Clin. Exp. Pharmacol. Physiol. 34, 695 (2007).
23. B. Petri, A. Bootz, A. Khalansky, T. Hekmatara, R. Muller, R. Uhl, J. Kreuter, and S. Gelperina, Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J. Control Release 117, 51 (2007).